Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (201-210 of 286) with videos related to

Pageof 29
Sort By:
Journal of Critical Care|March 31, 2009
The diagnosis of myocardial infarction in critically ill patients: an agreement studyWendy Lim, Andrea Tkaczyk, Paula Holinski, et al.
Thrombosis and Haemostasis|August 15, 2014
Comment on: editorial by Husted et al. "Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel". (Thromb Haemost 2014; 111: 781-782)Jack Ansell, Mark Crowther, Allison Burnett, et al.
Thrombosis and Haemostasis|February 26, 2021
Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding PatientsTruman J Milling, Ben King, Patrick Yue, et al.
BMJ Open|August 11, 2018
Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaireChatree Chai-Adisaksopha, Mark W Skinner, Randall Curtis, et al.
American Journal of Hematology|July 18, 2009
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: PreventionDavid Garcia, Walter Ageno, Henry Bussey, et al.
Thrombosis and Haemostasis|January 16, 2020
Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsArjun K Pandey, Ke Xu, Li Zhang, et al.
Journal of Thrombosis and Haemostasis : JTH|September 4, 2020
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisStéphane Zuily, Hannah Cohen, David Isenberg, et al.
Blood|August 21, 2004
Patients with severe sepsis vary markedly in their ability to generate activated protein CPatricia C Y Liaw, Charles T Esmon, Kamyar Kahnamoui, et al.
Journal of Thrombosis and Haemostasis : JTH|July 28, 2019
The risk of major bleeding in patients with suspected heparin-induced thrombocytopeniaAllyson M Pishko, Daniel S Lefler, Phyllis Gimotty, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2024
Evaluation of the MRX PT DOAC assay for detection of clinically relevant factor Xa inhibitor drug levelsBrittany Salter, Karen Moffat, Stephen Carlino, et al.
Pageof 29

Showing results (201-210 of 286) with videos related to

Sort By:
Pageof 29
Journal of Critical Care|March 31, 2009
The diagnosis of myocardial infarction in critically ill patients: an agreement studyWendy Lim, Andrea Tkaczyk, Paula Holinski, et al.
Thrombosis and Haemostasis|August 15, 2014
Comment on: editorial by Husted et al. "Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel". (Thromb Haemost 2014; 111: 781-782)Jack Ansell, Mark Crowther, Allison Burnett, et al.
Thrombosis and Haemostasis|February 26, 2021
Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding PatientsTruman J Milling, Ben King, Patrick Yue, et al.
BMJ Open|August 11, 2018
Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaireChatree Chai-Adisaksopha, Mark W Skinner, Randall Curtis, et al.
American Journal of Hematology|July 18, 2009
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: PreventionDavid Garcia, Walter Ageno, Henry Bussey, et al.
Thrombosis and Haemostasis|January 16, 2020
Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsArjun K Pandey, Ke Xu, Li Zhang, et al.
Journal of Thrombosis and Haemostasis : JTH|September 4, 2020
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisStéphane Zuily, Hannah Cohen, David Isenberg, et al.
Blood|August 21, 2004
Patients with severe sepsis vary markedly in their ability to generate activated protein CPatricia C Y Liaw, Charles T Esmon, Kamyar Kahnamoui, et al.
Journal of Thrombosis and Haemostasis : JTH|July 28, 2019
The risk of major bleeding in patients with suspected heparin-induced thrombocytopeniaAllyson M Pishko, Daniel S Lefler, Phyllis Gimotty, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2024
Evaluation of the MRX PT DOAC assay for detection of clinically relevant factor Xa inhibitor drug levelsBrittany Salter, Karen Moffat, Stephen Carlino, et al.
Pageof 29